VETRIX® harnesses the natural capabilities of the patients existing stem cells by attracting these progenitor cells into the biological scaffold. Once the patients cells have migrated into the VETRIX® bioscaffold, the cells lay down collagen which, in turn, shares signals to differentiate into the appropriate tissue. With this site specific healing capability, VETRIX® can fully regenerate tissue ranging from skin, muscular defects, intestinal lining and others. Even a damaged cornea can be fully restored using VETRIX® Ocular Discs.
Before VETRIX®, the use of extracellular matrix (ECM) widely infiltrated the human field of medicine. Originally developed at Purdue University, a team of researchers discovered the regenerative capabilities of small intestinal submucosa (SIS) ECM as a material able to fully regenerate tissue of various kinds. As the team of scientists imagined the possibilities of regenerative medicine, the rights to SIS were farmed to various companies throughout the human medical industry. To one company the cardiovascular rights were granted (CorMatrix), to another SIS was given for use to treat burn and dermatologic patients (Smith and Nephew), and still to another, Cook Biotech, the material has essentially been adopted as the standard of care for hernia repair. As the various applications became globally adopted for human implications, there was a void in veterinary medicine. Built upon the shoulders of proven research, VETRIX® was born. Today VETRIX® serves as the gold standard in biological regenerative veterinary medicine, offering the most scientifically proven biological scaffold on the market.
Today VETRIX® services veterinary practitioners across the globe. More and more, veterinarians ranging from university and specialty practices to general hospitals are reaching for VETRIX® to provide the very best care to their patients. From North America to Europe to Asia, VETRIX® provides its cutting edge technology with exceptional service.